Pfizer, Celgene's Brazilian subsidiaries, others, queried about substitutes in AbbVie-Allergan deal
Brazilian subsidiaries of Pfizer, Celgene, Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson and UCB were asked by the national competition authority reviewing the AbbVie-Allergan deal whether there are close substitutes for...To view the full article, register now.
Already a subscriber? Click here to view full article